InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

Avantor, Inc.

AVTR Clue Score37
United States Fiscal year ends December CIK 0001722482 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

106
Insider
Date
Role
Action
Shares
Price
Amount
Steven W Eck
5 Sep 2024
SVP & Chief Accounting Officer
Sell
3,525
$25.06
$88.34K
Christophe Couturier
29 Feb 2024
EVP, Amea
Sell
13,074
$24.53
$320.71K
James Bramwell
29 Feb 2024
EVP Sales, Customer Excellence
Sell
4,910
$24.52
$120.39K
James Bramwell
27 Feb 2024
EVP Sales, Customer Excellence
Sell
6,203
$24.49
$151.91K
Steven W Eck
7 Sep 2023
SVP & Chief Accounting Officer
Sell
7,577
$20.64
$156.39K
Frederic Vanderhaegen
25 Aug 2023
EVP, Americas and Europe
Sell
25,000
$21.47
$536.75K
Gerard Brophy
3 Mar 2023
EVP, Biopharma Production
Sell
3,914
$25.00
$97.85K
Christophe Couturier
28 Feb 2023
EVP, Amea
Sell
2,324
$24.32
$56.52K
Gerard Brophy
27 Feb 2023
EVP, Biopharma Production
Sell
3,059
$25.00
$76.48K
Christophe Couturier
23 Feb 2023
EVP, Amea
Sell
3,078
$24.24
$74.61K
Christophe Couturier
22 Feb 2023
EVP, Amea
Sell
19,160
$24.12
$462.14K
Gerard Brophy
2 Feb 2023
EVP, Biopharma Production
Sell
11,339
$25.06
$284.16K
Frederic Vanderhaegen
23 May 2022
EVP, Americas & Europe
Sell
39,000
$31.61
$1.23M
Gerard Brophy
20 May 2022
EVP, Biopharma Production
Sell
19,603
$31.27
$612.99K
Gerard Brophy
1 Mar 2022
EVP, Biopharma Production
Sell
2,027
$34.47
$69.87K
Gerard Brophy
23 Feb 2022
EVP, Biopharma Production
Sell
3,059
$33.79
$103.36K
Gerard Brophy
5 Jan 2022
EVP, Biopharma Production
Sell
11,551
$38.65
$446.45K
Rajiv Gupta
1 Dec 2021
Director
Sell
100,000
$39.30
$3.93M
Frederic Vanderhaegen
11 Nov 2021
EVP, Europe
Sell
60,804
$38.41
$2.34M
Rajiv Gupta
1 Nov 2021
Director
Sell
100,000
$40.31
$4.03M
Rajiv Gupta
1 Oct 2021
Director
Sell
100,000
$39.94
$3.99M
Michael Stubblefield
20 Sep 2021
President and CEO
Sell
141,300
$42.37
$5.99M
Rajiv Gupta
1 Sep 2021
Director
Sell
100,000
$39.45
$3.95M
Steven W Eck
26 Aug 2021
SVP & Chief Accounting Officer
Sell
17,383
$40.08
$696.71K
Rajiv Gupta
20 Aug 2021
Director
Sell
100,000
$38.81
$3.88M
James Bramwell
20 Jul 2021
EVP, Strategic Partners
Sell
6,112
$37.00
$226.14K
James Bramwell
9 Jul 2021
EVP, Strategic Partners
Sell
12,221
$35.64
$435.56K
James Bramwell
9 Jul 2021
EVP, Strategic Partners
Sell
6,110
$35.56
$217.27K
Christophe Couturier
28 Jun 2021
EVP, Amea
Sell
28,096
$35.73
$1.00M
Rajiv Gupta
25 Jun 2021
Director
Sell
68,605
$35.32
$2.42M
Rajiv Gupta
27 May 2021
Director
Sell indirect
78,109
$31.94
$2.49M
Rajiv Gupta
26 May 2021
Director
Sell indirect
150,000
$31.89
$4.78M
Rajiv Gupta
24 May 2021
Director
Sell indirect
157,571
$31.57
$4.97M
Rajiv Gupta
24 May 2021
Director
Sell indirect
180,000
$31.74
$5.71M
Michael Wondrasch
21 May 2021
EVP & CIO
Sell
18,488
$31.41
$580.71K
Gerard Brophy
20 May 2021
EVP, Biopharma Production
Sell
19,603
$31.10
$609.65K
Christophe Couturier
20 May 2021
EVP, Amea
Sell
25,010
$31.13
$778.56K
Justin Miller
20 May 2021
EVP & General Counsel
Sell
18,488
$31.12
$575.35K
Jo Natauri
11 May 2021
Director
Sell indirect
2,626,771
$30.68
$80.59M
James Bramwell
12 Apr 2021
EVP, Strategic Partners
Sell
2,505
$32.00
$80.16K
Frederic Vanderhaegen
12 Apr 2021
EVP, Europe
Sell
17,075
$31.83
$543.50K
Frederic Vanderhaegen
12 Apr 2021
EVP, Europe
Sell
10,000
$31.75
$317.50K
Frederic Vanderhaegen
9 Mar 2021
EVP, Europe
Sell
10,000
$28.21
$282.10K
Michael Wondrasch
2 Mar 2021
EVP & CIO
Sell
3,036
$28.71
$87.16K
Gerard Brophy
24 Feb 2021
EVP, Biopharma Production
Sell
3,059
$27.93
$85.44K
James Bramwell
11 Jan 2021
EVP, Strategic Partners
Sell
2,505
$30.00
$75.15K
Gerard Brophy
6 Jan 2021
EVP, Biopharma Production
Sell
11,509
$27.24
$313.51K
James Bramwell
21 Dec 2020
EVP, Strategic Partners
Sell
10,020
$27.14
$271.94K
Christi Shaw
11 Dec 2020
Director
Sell
14,286
$26.68
$381.15K
New Mountain Investments III, LLC
10 Nov 2020
10% owner
Sell indirect
36,016,093
$24.81
$893.49M
Justin Miller
8 Sep 2020
EVP & General Counsel
Sell
22,887
$21.17
$484.52K
New Mountain Investments III, LLC
21 Aug 2020
10% owner
Sell indirect
25,575,472
$19.51
$498.89M
Goldman Sachs & Co. LLC
21 Aug 2020
10% owner
Sell indirect
15,397,005
$19.51
$300.34M
Jo Natauri
21 Aug 2020
Director
Sell indirect
15,397,005
$19.51
$300.34M
Goldman Sachs & Co. LLC
26 May 2020
10% owner
Sell indirect
13,726,411
$15.90
$218.25M
Thomas Connolly
26 May 2020
Director
Sell indirect
13,726,411
$15.90
$218.25M
Jo Natauri
26 May 2020
Director
Sell indirect
13,726,411
$15.90
$218.25M
New Mountain Investments III, LLC
26 May 2020
10% owner
Sell indirect
20,886,424
$15.90
$332.19M
Michael Wondrasch
22 May 2020
EVP & CIO
Sell
22,987
$17.82
$409.63K
Gerard Brophy
20 May 2020
EVP, Biopharma Production
Sell
25,495
$17.36
$442.59K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
9,922
$14.80
$146.85K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
5,164
$14.79
$76.38K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
100
$14.79
$1.48K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
3,800
$14.78
$56.16K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
100
$14.78
$1.48K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
4,146
$14.76
$61.19K
Thomas Connolly
25 Sep 2019
Director
Sell indirect
1,768
$14.70
$25.99K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
9,922
$14.80
$146.85K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
5,164
$14.79
$76.38K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
100
$14.79
$1.48K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
3,800
$14.78
$56.16K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
100
$14.78
$1.48K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
4,146
$14.76
$61.19K
Goldman Sachs & Co. LLC
25 Sep 2019
10% owner
Sell indirect
1,768
$14.70
$25.99K
Jo Natauri
25 Sep 2019
Director
Sell indirect
9,922
$14.80
$146.85K
Jo Natauri
25 Sep 2019
Director
Sell indirect
5,164
$14.79
$76.38K
Jo Natauri
25 Sep 2019
Director
Sell indirect
100
$14.79
$1.48K
Jo Natauri
25 Sep 2019
Director
Sell indirect
3,800
$14.78
$56.16K
Jo Natauri
25 Sep 2019
Director
Sell indirect
100
$14.78
$1.48K
Jo Natauri
25 Sep 2019
Director
Sell indirect
4,146
$14.76
$61.19K
Jo Natauri
25 Sep 2019
Director
Sell indirect
1,768
$14.70
$25.99K
Thomas Connolly
9 Sep 2019
Director
Sell indirect
149,694
$16.46
$2.46M
Goldman Sachs & Co. LLC
9 Sep 2019
10% owner
Sell indirect
149,694
$16.46
$2.46M
Jo Natauri
9 Sep 2019
Director
Sell indirect
149,694
$16.46
$2.46M
Thomas Connolly
6 Sep 2019
Director
Sell indirect
49,200
$17.06
$839.54K
Thomas Connolly
6 Sep 2019
Director
Sell indirect
67,437
$16.51
$1.11M
Goldman Sachs & Co. LLC
6 Sep 2019
10% owner
Sell indirect
49,200
$17.06
$839.54K
Goldman Sachs & Co. LLC
6 Sep 2019
10% owner
Sell indirect
67,437
$16.51
$1.11M
Jo Natauri
6 Sep 2019
Director
Sell indirect
49,200
$17.06
$839.54K
Jo Natauri
6 Sep 2019
Director
Sell indirect
67,437
$16.51
$1.11M
Thomas Connolly
12 Aug 2019
Director
Sell indirect
9
$16.66
$149.94
Thomas Connolly
12 Aug 2019
Director
Sell indirect
16,245
$16.51
$268.26K
Goldman Sachs & Co. LLC
12 Aug 2019
10% owner
Sell indirect
9
$16.66
$149.94
Goldman Sachs & Co. LLC
12 Aug 2019
10% owner
Sell indirect
16,245
$16.51
$268.26K
Jo Natauri
12 Aug 2019
Director
Sell indirect
9
$16.66
$149.94
Jo Natauri
12 Aug 2019
Director
Sell indirect
16,245
$16.51
$268.26K
Thomas Connolly
6 Aug 2019
Director
Sell indirect
88
$16.66
$1.47K
Goldman Sachs & Co. LLC
6 Aug 2019
10% owner
Sell indirect
88
$16.66
$1.47K
Jo Natauri
6 Aug 2019
Director
Sell indirect
88
$16.66
$1.47K
Thomas Connolly
31 Jul 2019
Director
Sell indirect
55
$17.55
$965.12
Goldman Sachs & Co. LLC
31 Jul 2019
10% owner
Sell indirect
55
$17.55
$965.12
Jo Natauri
31 Jul 2019
Director
Sell indirect
55
$17.55
$965.12
New Mountain Investments III, LLC
21 May 2019
10% owner
Sell indirect
100
$14.00
$1.40K
Thomas Connolly
17 May 2019
Director
Sell indirect
14,049
$14.00
$196.69K
Goldman Sachs & Co. LLC
17 May 2019
10% owner
Sell indirect
14,049
$14.00
$196.69K
Jo Natauri
17 May 2019
Director
Sell indirect
14,049
$14.00
$196.69K
Show all 221 transactions →

What was left out

Form 4 filings counted 437
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 35
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 259,396,189
Sales filed before the plan box existed 100
History held since 23 May 2019